Ceres Nanosciences is a privately held company, located in the United States, in Northern Virginia, focused on the commercialization of the Nanotrap® particle technology for sample preparation. The Nanotrap particle technology improves diagnostic testing and life science research by capturing, concentrating, and preserving low abundance analytes from biological samples. The Nanotrap particle technology was invented at George Mason University. With support from the Defense Advanced Research Projects Agency, the Bill and Melinda Gates Foundation, the Defense Threat Reduction Agency, the NIH, and the Commonwealth of Virginia, Ceres is focused on incorporating this technology into a range of innovative diagnostic products.
The Ceres Nanosciences Nanotrap® Virus Capture Kit provide a way to concentrate viruses from complex biological matrices in order to have high quality input material for your downstream analytical methods
The Ceres Nanosciences Nanotrap® Protein particles utilize affinity capture and size exclusion to attract and bind low abundance proteins, while excluding unwanted high abundance and high molecular weight interfering molecules.
2mL of Nanotrap ® Non-Magnetic Virus Particles (10 x 0.2 mL)
The Ceres Nanosciences Nanotrap® Virus Capture Kit provide a way to concentrate viruses from complex biological matrices in order to have high quality input material for your downstream analytical methods
The Ceres Nanosciences Nanotrap® Protein particles utilize affinity capture and size exclusion to attract and bind low abundance proteins, while excluding unwanted high abundance and high molecular weight interfering molecules
The Ceres Nanosciences Nanotrap® Protein particles utilize affinity capture and size exclusion to attract and bind low abundance proteins, while excluding unwanted high abundance and high molecular weight interfering molecules.
The Ceres Nanosciences Nanotrap® Protein particles utilize affinity capture and size exclusion to attract and bind low abundance proteins, while excluding unwanted high abundance and high molecular weight interfering molecules.
Collaborate with Ceres Nanosciences to optimize the Nanotrap® technology platform for the capture, concentration, or preservation of your valuable analytes and pathogens.
Particles under development for cfDNA, Extracellular Vesicles, Bacteria, Drug-of-Abuse and Hormones
